Oncobiologics Inc. | Cash Flow
Fiscal year is October-September. All values USD Thousands.
2014
2015
2016
2017
Net Income before Extraordinaries
13,732.50
48,669.90
53,302.00
38,849.10
Depreciation, Depletion & Amortization
878.50
1,824.60
2,394.30
2,692.10
Other Funds
23.20
-
4,631.40
216.10
Funds from Operations
8,883.30
35,655.10
38,430.50
26,667.60
Changes in Working Capital
1,862.80
8,178.90
7,052.20
11,162.50
Net Operating Cash Flow
7,020.50
27,476.20
45,482.70
15,505.10
Capital Expenditures
2,366.80
8,804.20
1,098.20
292.10
Sale of Fixed Assets & Businesses
-
401.00
-
-
Purchase/Sale of Investments
3.40
2.20
-
-
Net Investing Cash Flow
2,370.20
8,405.50
1,098.20
292.10
Issuance/Reduction of Debt, Net
4,333.70
1,579.30
13,344.90
11,291.20
Net Financing Cash Flow
11,477.50
42,603.30
39,861.80
16,630.80
Net Change in Cash
2,086.90
6,721.70
6,719.10
833.60
Free Cash Flow
9,387.20
36,280.40
46,580.90
15,797.10
Change in Capital Stock
7,167.00
41,024.00
48,575.30
5,123.50
About Oncobiologics
View Profile
